HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Authors' reply re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: Time range for treatment with magnesium sulphate.

AuthorsHanne Trap Wolf, Jesper Brok, Tine Brink Henriksen, Hanne Kristine Hegaard, Gorm Greisen, Tom Weber, Ole Pryds, Jannie Dalby Salvig, Morten Hedegaard, Anja Pinborg, Lene Drasbek Huusom
JournalBJOG : an international journal of obstetrics and gynaecology (BJOG) Vol. 127 Issue 10 Pg. 1296-1297 (09 2020) ISSN: 1471-0528 [Electronic] England
PMID32427415 (Publication Type: Letter, Comment)
Chemical References
  • Magnesium Sulfate
Topics
  • Cerebral Palsy
  • Double-Blind Method
  • Female
  • Gestational Age
  • Humans
  • Infant
  • Infant, Newborn
  • Magnesium Sulfate
  • Parturition
  • Pregnancy
  • Premature Birth

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: